(Q34669198)

3 August 2017

1 reference

title

Review article: medical treatment of severe ulcerative colitis (English)

1 reference

3 August 2017

1 reference

Daperno M

1

1 reference

3 August 2017

Sostegni R

2

1 reference

3 August 2017

Rocca R

3

1 reference

3 August 2017

Rigazio C

4

1 reference

3 August 2017

Scaglione N

5

1 reference

3 August 2017

Castellino F

6

1 reference

3 August 2017

Ercole E

7

1 reference

3 August 2017

Pera A

8

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

Alimentary Pharmacology & Therapeutics

3 August 2017

published in

1 reference

3 August 2017

volume

16 Suppl 4

1 reference

3 August 2017

page(s)

7-12

1 reference

Predicting outcome in severe ulcerative colitis

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.2.X

Cortisone in ulcerative colitis; final report on a therapeutic trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.2.X

Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.2.X

Assessment of severity in colitis: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.2.X

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.2.X

Intestinal gas in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.2.X

THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.2.X

The management of fulminant ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.2.X

Intensive intravenous regimen for severe attacks of ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.2.X

Out-patient treatment of ulcerative colitis. Comparison between three doses of oral prednisone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.2.X

A Comparison of Oral Prednisolone Given as Single or Multiple Daily Doses for Active Proctocolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.2.X

Controlled trial of bowel rest in the treatment of severe acute colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.2.X

Double blind controlled trial of oral vancomycin as adjunctive treatment in acute exacerbations of idiopathic colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.2.X

Cyclosporine in severe ulcerative colitis refractory to steroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.2.X

Intravenous cyclosporin in ulcerative colitis: a five-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.2.X

Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.2.X

Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S4.2.X

10.1046/J.1365-2036.16.S4.2.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference